Mauro Mileni

Mauro Mileni is the Founder and CEO of Abilita Therapeutics, Inc., a biotechnology company based in the Greater San Diego Area.12 He established the company in April 2014 and is the inventor of its core EMP™ technology.2

Education and Background

Mauro Mileni has an extensive educational background in biochemistry, biophysics, and molecular biology:

• He earned his Bachelor's and Master's degrees in Microbiology-Molecular Biology from Università Politecnica delle Marche.1
• He obtained a Master's degree in Biochemistry and Molecular Biology from the University of Wolverhampton.1
• Mileni completed his Doctor of Philosophy (PhD) in Biochemistry, Biophysics, and Molecular Biology at the Max Planck Institute of Biophysics/Johann W. Goethe Universitaet in Frankfurt am Main.1

Professional Experience

As the Founder and CEO of Abilita Therapeutics, Inc., Mauro Mileni has been leading the company since its inception in April 2014.1 The company focuses on discovering and developing membrane protein-targeted therapeutics.4 Under his leadership, Abilita Therapeutics has achieved significant milestones in the biotechnology industry.4

Expertise and Contributions

Mauro Mileni is recognized as an accomplished biochemist, biophysicist, and molecular biologist with extensive knowledge in microbiology. His expertise has been instrumental in driving innovation at Abilita Therapeutics, particularly in the development of the company's core EMP™ technology.2

Mileni actively shares insights and updates about his work and the biotechnology industry on his LinkedIn profile, where his username is mauro-mileni-4b36703.3456